Why Should We Recommend Pneumococcal Vaccine in Patients With Chronic Heart Diseases?
Rev Esp Cardiol (Engl Ed). 2018 Jan;71(1):57-58.
doi: 10.1016/j.rec.2017.08.020.
Epub 2017 Nov 14.
[Article in
English,
Spanish]
Affiliations
- 1 Sociedad Española de Quimioterapia, Infección y Vacunas, Hospital Clínico San Carlos, Universidad Complutense, Madrid, Spain. Electronic address: fgromo@salud.madrid.org.
- 2 Sociedad Española de Cardiología, Hospital Ramón y Cajal, Universidad de Alcalá, Madrid, Spain.
No abstract available
MeSH terms
-
Adolescent
-
Adult
-
Aged
-
Chronic Disease
-
Female
-
Heart Diseases / complications*
-
Heart Diseases / mortality
-
Humans
-
Male
-
Middle Aged
-
Pneumococcal Infections / complications
-
Pneumococcal Infections / mortality
-
Pneumococcal Infections / prevention & control*
-
Pneumococcal Vaccines / pharmacology*
-
Risk Factors
-
Spain / epidemiology
-
Streptococcus pneumoniae / immunology*
-
Survival Rate / trends
-
Vaccination / methods*
-
Young Adult